Method for preventing cancer metastasis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9161944
APP PUB NO 20130029925A1
SERIAL NO

13577734

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of a specific family of glycerolipid compounds of formula (I) described in the detailed description or the manufacture of a medicament for the prevention or for the treatment of cancer metastasis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)101 RUE DE TOLBIAC PARIS 75013
UNIVERSITE FRANCOIS-RABELAIS DE TOURS60 RUE DU PLAT D'ETAIN TOURS F-37000
UNIVERSITE DE BRETAGNE OCCIDENTALE (U B O )29200 BREST

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bougnoux, Philippe Tours, FR 1 76
Chantome, Aurelle Tours, FR 1 0
Corbel, Bernard Brest, FR 1 76
Girault, Alban Tours, FR 1 76
Haelters, Jean-Pierre Brest, FR 2 76
Joulin, Virginie Villejuif, FR 2 76
Potier-Cartereau, Marie Tours, FR 2 77
Simon, Gaelle Brest, FR 1 76
Vandier, Christophe Tours, FR 4 77

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 20, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00